By Dr. Danielle Lewis, NMD

If you have PCOS and you have been struggling with your weight, your cycles, your skin, or your energy for years, you have probably been told some version of the same thing: lose weight and your PCOS will improve. Or: follow this diet, cut out carbs, exercise more.

What you may not have been told is why weight and PCOS are so intertwined in the first place. And if you were not told why, the advice to just lose weight probably felt both impossible and unfair.

There is a specific biological reason that PCOS makes weight management so difficult. And there is now a class of medications that addresses that reason directly. This post is about that connection.

PCOS Is Not Primarily a Reproductive Disorder

Most women are introduced to PCOS through its reproductive symptoms: irregular cycles, lack of ovulation, or difficulty conceiving. But the reproductive manifestations of PCOS are downstream of a more fundamental problem in the majority of cases.

For approximately 70 to 80 percent of women with PCOS, the primary driver is insulin resistance. The ovarian dysfunction, the androgen excess, the cycle irregularity: these are largely consequences of hyperinsulinemia, which is the medical term for chronically elevated insulin.

Here is how the cascade works. When your cells are resistant to insulin, your pancreas compensates by producing more of it. Elevated insulin reaches the ovaries, where it directly stimulates androgen (primarily testosterone) production. Elevated androgens suppress ovulation and disrupt the normal hormonal cycle. Excess androgen also reduces SHBG, sex hormone-binding globulin, which means more free testosterone circulates in the bloodstream, amplifying androgenic symptoms like acne, excess hair growth, and scalp hair thinning.

Elevated insulin simultaneously promotes fat storage, particularly visceral abdominal fat. And visceral fat itself produces inflammatory signals and additional androgens, tightening the cycle further.

Why Weight Loss Is So Hard with PCOS

When you understand the mechanism above, the weight problem becomes clearer. It is not that women with PCOS eat more or exercise less. It is that their cells are resistant to insulin, producing a hormonal environment that actively resists fat metabolism and promotes fat storage.

Additionally, PCOS is associated with reduced insulin-stimulated glucose uptake in muscle tissue. This means that exercise, which typically improves insulin sensitivity, requires more effort to produce the same metabolic benefit in women with PCOS than in women without it.

The conventional advice to diet and exercise more is not wrong. But it is addressing the consequences of insulin resistance rather than the root. Without addressing the insulin component, progress is difficult, frustrating, and often unsustainable.

"Elevated insulin in PCOS signals the ovaries to produce more testosterone. More testosterone disrupts ovulation. It is an insulin problem expressing itself through the reproductive system."

Where GLP-1 Therapy Changes the Picture

GLP-1 receptor agonists address PCOS at the point where it actually begins: insulin resistance.

By improving insulin sensitivity and reducing overall insulin levels, GLP-1 therapy can interrupt the cascade that drives androgen excess in PCOS. Lower insulin means less ovarian androgen stimulation, which means the downstream PCOS symptoms often improve alongside metabolic markers.

Clinical evidence in PCOS populations shows improvements in fasting insulin, HbA1c, free testosterone levels, SHBG (higher SHBG means less free androgen), cycle regularity in some patients, and visceral fat reduction specifically. These are not just cosmetic improvements. They are meaningful changes to the hormonal environment driving PCOS.

PCOS and Perimenopause: The Overlap That Needs Specific Attention

One clinical picture that gets inadequate attention is the woman with PCOS entering perimenopause. This transition is particularly complex, and at Harmony we see it regularly.

The insulin resistance of PCOS does not resolve at menopause. It persists and can worsen as the additional metabolic changes of estrogen decline compound the existing insulin dysfunction. Perimenopausal hormonal fluctuations can make PCOS-related cycle irregularity harder to distinguish from perimenopausal irregularity, delaying appropriate care for both.

The androgen picture also shifts: some women with PCOS see their testosterone levels decline in perimenopause, which can cause unexpected changes in symptoms, while others continue to experience androgen excess. Individual evaluation matters enormously here.

For women with PCOS moving through perimenopause, a comprehensive protocol that addresses both the insulin resistance and the hormonal transition is significantly more effective than addressing only one side of the picture.

The Comprehensive PCOS Evaluation at Harmony

When we evaluate PCOS at Harmony, we do not stop at diagnosis. We aim to understand your specific hormonal and metabolic profile so that treatment can be targeted.

The lab panel for PCOS typically includes: fasting insulin and glucose (to quantify insulin resistance), free and total testosterone, DHEA-S, SHBG, a full thyroid panel with antibodies (thyroid autoimmunity is more common in women with PCOS and is frequently missed), hs-CRP for inflammation, and a full sex hormone panel including estradiol, progesterone, and FSH/LH ratio.

You can order many of these through our Harmony Functional Health Lab Store without needing a referral. The link is https://us.fullscript.com/s/harmony/shop. Coming to your consultation with lab results already in hand makes the first appointment significantly more productive.

Treatment: More Than Just Medication

GLP-1 therapy at Harmony is always part of a broader protocol. For PCOS patients, that protocol typically includes dietary guidance focused on blood sugar stability (not just calorie restriction), strength training programming to improve insulin sensitivity in muscle tissue, and targeted supplementation (inositol in the myo-inositol form has strong evidence for PCOS insulin resistance specifically).

For PCOS patients in perimenopause, we also evaluate whether hormone optimization is appropriate alongside the insulin-focused interventions.

The goal is not to manage PCOS indefinitely on medication. The goal is to correct the metabolic environment enough that your body can function more normally, and to address the underlying drivers so that improvements can be maintained.

By Dr. Danielle Lewis, NMD

If PCOS has been a constant source of frustration and you feel like you have never been given the real explanation, let's change that. Book a free 15-minute discovery call at Harmony Integrative Healthcare. The consultation and lab portions of our pathways qualify for HSA and FSA reimbursement.